Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study.
Journal: Therapeutic innovation & regulatory science
Published: March 06, 2023
Assessment of the Impact of Mandated Postmarketing Pediatric-Focused Safety Reviews on Safety-Related Regulatory Actions 2013-2019.
Journal: Clinical pharmacology and therapeutics
Published: October 18, 2022
Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports.
Journal: Pharmaceutical medicine
Published: August 05, 2021
Information Visualization Platform for Postmarket Surveillance Decision Support.
Journal: Drug safety
Published: May 24, 2020
Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
Journal: Pharmacotherapy
Published: September 04, 2019
Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance.
Journal: Drug safety
Published: December 21, 2018
An Evaluation of "Drug Ineffective" Postmarketing Reports in Drug Safety Surveillance.
Journal: Drugs - real world outcomes
Published: February 25, 2018
Pediatric post-marketing safety systems in North America: assessment of the current status.
Journal: Pharmacoepidemiology and drug safety
Published: January 22, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026